On September 21st, 2012, BusinessWeek reported that Vivus Inc. believes advisers to the European Union's health agency will recommend against approving its new diet drug Qsymia. One of the...
(PRWeb October 10, 2012)
Read the full story at http://www.prweb.com/releases/2012/10/prweb9976902.htm